This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2014
Title: Naomi Nagaoka: Innovator in Pharmaceutical Composition
Introduction
Naomi Nagaoka is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the solubility and absorbability of poorly soluble substances. With a total of 2 patents to her name, Nagaoka's work is recognized for its innovative approaches to drug formulation.
Latest Patents
Nagaoka's latest patents include a finely divided composition containing a poorly water-soluble substance. This method involves preparing a composition with a median diameter of not more than 1 μm, which includes a poorly water-soluble substance, polyvinylpyrrolidone or a vinylpyrrolidone-vinyl acetate copolymer, and an auxiliary dispersion stabilizer. This innovative composition allows for sufficient micronization of the poorly soluble substance, resulting in improved absorbability. Another notable patent is for a film-coated scored tablet, which optimizes the forms of respective parts associated with a score line to facilitate easier division along the score line.
Career Highlights
Nagaoka is currently employed at Takeda Pharmaceutical Company Limited, where she continues to advance her research and development efforts. Her work at Takeda has positioned her as a key player in the pharmaceutical industry, contributing to the development of effective drug formulations.
Collaborations
Nagaoka collaborates with esteemed colleagues, including Akihiko Ono and Shigeyuki Marunaka. These partnerships enhance her research capabilities and foster innovation within her projects.
Conclusion
Naomi Nagaoka's contributions to pharmaceutical innovations demonstrate her expertise and commitment to improving drug formulations. Her patents reflect a deep understanding of the challenges associated with poorly soluble substances, making her a valuable asset in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
